Group 1 - Dongfeng Group announced a share repurchase plan, having repurchased approximately 12.69 million shares, accounting for about 0.68% of the total share capital, with a total expenditure of approximately RMB 50.13 million [1] - The highest repurchase price was RMB 4.85 per share, while the lowest was RMB 3.03 per share, exceeding the lower limit of the expected repurchase amount of RMB 50 million [1] - As of the report date, Dongfeng Group's market capitalization stands at RMB 8.9 billion [1] Group 2 - For the first half of 2025, Dongfeng Group's revenue composition is as follows: pharmaceutical packaging 41.31%, membrane new materials 34.19%, paper products 14.47%, other businesses 6.53%, and others 3.06% [1]

Group 1 - Dongfeng Group (SH 601515) announced the convening of its sixth fourth board meeting on August 27, 2025, to review the 2025 semi-annual report and its summary [1] - For the first half of 2025, Dongfeng Group's revenue composition was as follows: pharmaceutical packaging accounted for 41.31%, membrane new materials for 34.19%, paper products for 14.47%, other businesses for 6.53%, and others for 3.06% [1] - As of the report date, Dongfeng Group's market capitalization was 8.8 billion yuan [1]

Group 1 - The core revenue composition of Dongfeng Group for the year 2024 is as follows: pharmaceutical packaging accounts for 44.36%, membrane new materials for 27.58%, paper products for 10.08%, others for 7.4%, and cigarette labels for 6.2% [1] Group 2 - As of August 1, 2025, Dongfeng Group announced that it has repurchased approximately 7.68 million shares, representing about 0.41% of the company's total share capital [3] - The highest price for the repurchased shares was RMB 3.93 per share, while the lowest price was RMB 3.03 per share, with a total expenditure of approximately RMB 26.64 million [3]